Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-12-27
2005-12-27
Kemmerer, Elizabeth (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C536S023500, C514S012200, C424S185100
Reexamination Certificate
active
06979724
ABSTRACT:
The present invention relates to calcium channel compositions and methods of making and using same. In particular, the invention relates to calcium channel alpha2delta (α2δ) subunits and nucleic acid sequences encoding them. These compositions are useful in methods for identifying compounds that modulate the activity of calcium channels and for identifying compounds as therapeutic for disease.
REFERENCES:
patent: 4650764 (1987-03-01), Temin et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4797368 (1989-01-01), Carter et al.
patent: 4861719 (1989-08-01), Miller
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 4980289 (1990-12-01), Temin et al.
patent: 5124263 (1992-06-01), Temin et al.
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5312928 (1994-05-01), Goldin et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5407820 (1995-04-01), Ellis et al.
patent: 5429921 (1995-07-01), Harpold et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5559004 (1996-09-01), Steinhardt et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5618720 (1997-04-01), Ellis et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5686241 (1997-11-01), Ellis et al.
patent: 5710250 (1998-01-01), Ellis et al.
patent: 5792846 (1998-08-01), Harpold et al.
patent: 5843742 (1998-12-01), Natsoulis et al.
patent: 453243 (1991-10-01), None
patent: 178220 (1992-01-01), None
patent: 185573 (1992-05-01), None
patent: 488528 (1995-11-01), None
patent: 89/07150 (1989-08-01), None
patent: 90/02806 (1990-03-01), None
patent: 90/13678 (1990-11-01), None
patent: 91/18088 (1991-11-01), None
patent: 92/05263 (1992-04-01), None
patent: 93/09239 (1993-05-01), None
patent: 94/12649 (1994-06-01), None
patent: 94/21807 (1994-09-01), None
patent: 94/26914 (1994-11-01), None
patent: 94/28152 (1994-12-01), None
patent: 94/28938 (1994-12-01), None
patent: 95/02697 (1995-01-01), None
patent: 95/18863 (1995-07-01), None
patent: 95/21931 (1995-08-01), None
patent: 95/07358 (1996-03-01), None
patent: 96/15244 (1996-05-01), None
patent: 96/17823 (1996-06-01), None
patent: 96/22378 (1996-07-01), None
patent: 96/25508 (1996-08-01), None
Barclay et al. Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar purkinje cells. J Neurosci 21(16):6095-6104, 2001.
Carboni et al. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium singaling and distruption of mitochondria membrane integrity. Oncogene 22:615-626, 2003.
Felix, R. Channelopathies: ion channel defects linked to heritable clinical disorders. J Med Genet 37:729-740, 2000.
Gao et al. Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J Biol Chem 276(16):12237-12242, 2000.
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29(37): 8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Hering et al. Molecular determinants of inactivation in voltage-gated Ca2+ channels. J Physiol 528(2): 237-240, 2000.
Genbank Accession No. AF040709, direct submission, Nov. 5, 1998.
Genbank Accession No. AAC70914, direct submission, Nov. 4, 1998.
McFadzean et al. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Brit J pharmcol 135: 1-13, 2002.
Genbank Accession No. AAB96913, Wei et al., direct submission, Jan. 17, 1998.
Genbank Accession No. AF042792, Wei et al., direct submission, Jan. 17, 1998.
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Research Disclosure 37105, “Recombinant Herpesvirus Lacking Gene for Glycoprotein L,” 1995, p. 124-130.
Alton et al., “Non-Invasive Liposome-Mediated Gene Delivery Can Correct the Ion Transport Defect in Cystic Fibrosis Mutant Mice,”Nature Genet.5:135-142, 1993.
Angelotti and Hofmann, “Tissue-Specific Expression of Splice Variants of the Mouse Voltage-Gated Calcium Channel α2/δ Subunit,”FEBS397:331-337, 1996.
Ausubel et al.,Current Protocols in Molecular Biology,John Wiley & Sons, New York NY, 1989.
Bangalore et al., “Influence of L-Type Ca Channel α2/δ-Subunit on Ionic and Gating Current in Transiently Transfected HEK 293 Cells,”Am. J. Physiol.270 (5 Pt. 2):H1521-1528, 1996.
Barclay et al., “Mouse Models of Spike-Wave Epilepsy,” Epilepsia 40 (Supp.) 3:17-22, 1999.
Bateman et al., “Pfam 3.1: 1313 Multiple Alignments and Profile HMMs Match the Majority of Proteins,”Nucleic Acids Research27(1):260-262, 1999.
Baylin et al., “Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia,”Adv. Cancer Res.72:141-196, 1998.
Becker et al.,In Protein Expression in Animal Cells,Roth et al. (eds.), 1994.
Bender et al., “Evidence that the Packaging Signal of Moloney Murine Leukemia Virus Extends into the gag Region,”J. Virol.61:1639-1646, 1987.
Bernstein et al., “Gene Transfer with Retrovirus Vectors,”Genet. Eng.7:235-261, 1985.
Berridge et al., “Calcium—a Life and Death Signal,”Nature395:645-648, 1998.
Biel et al., “Primary Structure and Functional Expression of a High Voltage Activated Calcium Channel from Rabbit Lung,”FEBS269:409-412, 1990.
Black et al., “Identification and Cloning of Putative Human Neuronal Voltage-Gated Calcium Channel α-2 and α-3 Subunits: Neurologic Implications,”Mayo Clin. Proc.74(4):357-361, 1999.
Bork et al., “More von Willebrand Factor Type A Domains? Sequence Similarities with Malaria Thrombospondin-Related Anonymous Protein, Dihydropyridine-Sensitive Calcium Channel and Inter-α Trypsin Inhibitor,”Biochem. J.279:908-10, 1991.
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science247:1306-1310, 1990.
Brown and Gee, “Cloning and Deletion Mutagenesis of the α2/δ Calcium Channel Subunit from Porcine Cerebral Cortex. Expression of a Soluble Form of the Protein that Retains [3H] Gabapentin Binding Activity,”J. Biol. Chem.273:25458-25465, 1998.
Brust et al., “Human Neuronal Voltage-Dependent Calcium Channels: Studies on Subunit Structure and Role in Channel Assembly,”Neuropharmacol.32:1089-1102, 1993.
Burgess et al., “Mutation of the Ca2+Channel β Subunit Gene Cchb4 is Associated with Ataxia and Seizures in the Lethargic (1h) Mouse,”Cell88:385-392, 1997.
Burgess et al., “Possible Dissociation of the Heparin-Binding and Mitogenic Activities of Heparin-Binding (Acidic Fibroblast) Growth Factor-1 From Its Receptor-Binding Activities by Site-Directed Mutagenesis of a Single Lysine Residue,”The Journal of Cell Biology111:2129-2138, 1990.
Caplen et al., “Gene Therapy for Cystic Fibrosis in Humans by Liposome-Mediated DNA Transfer: The Production of Resources and the Regulatory Process,”Gene Ther.1:139-147, 1994.
Castellano and Perez-Reyes, “Molecular Diversity of Ca2+Channel
Duh Fuh-Mei
Gao Boning
Latif Farida
Lerman Michael Isaac
Minna John Dorrance
Bunner Bridget E.
Kemmerer Elizabeth
Klarquist & Sparkman, LLP
The Board of Regents of the University of Texas System
The United States of America as represented by the Secretary of
LandOfFree
Calcium channel proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium channel proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium channel proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3487145